Skip to Content

South Street Advisors LLC sells 2,355 Novo Nordisk A/S shares (NYSE:NVO)

South Street Advisors LLC sells 2,355 Novo Nordisk A/S shares (NYSE:NVO)

South Street Advisors LLC cut its stake in Novo Nordisk A/S (NYSE: NVO) by 1.5% during the third quarter, as stated in the most recent Form 13F filing that the company made with the Securities and Exchange Commission. Following the transaction during that period, the fund was left with 156,367 shares of the company’s stock after selling 2,355. Novo Nordisk A/S is the sixth largest holding South Street Advisors LLC has, and the company has this holding because the company accounts for 3.8% of the firm’s portfolio as a whole. South Street Advisors LLC disclosed to the Securities and Exchange Commission (SEC) in its most recent report that the value of its holdings in Novo Nordisk A/S was $15,579,000. This information was included in the report.

During the past few months, various other institutional investors and hedge funds have either increased or decreased the amount of this stock they are currently holding in their portfolios. Roundview Capital LLC’s holdings in Novo Nordisk A/S increased by 0.6 percent during the first three months of 2018 due to the company’s acquisition of additional shares. Since the end of the most recent financial quarter, Roundview Capital LLC has accumulated a total of 18,803 shares of the company’s stock, giving it a value of $2,088,000. Compared to the previous quarter, this represents an increase of 106 shares. BlackRock Inc. increased its holdings in Novo Nordisk A/S by 45.4% during the first three months of 2018. BlackRock Inc. purchased 1,571,747 shares of the company’s stock during the most recent fiscal quarter, bringing the total number of shares held by the company to 5,035,879, with a value of $559,235,000. This brought the total number of shares the company owned to $559,235,000. During the first three months of the year, Dimensional Fund Advisors LP was able to amass 0.9% more shares of Novo Nordisk A/S than previously. Dimensional Fund Advisors LP currently holds a total of 739,585 shares, estimated at $82,131,000. This was accomplished by purchasing 6,903 additional shares during the most recent fiscal quarter to achieve the desired result. The percentage of Novo Nordisk A/S stock that Blair William & Co. IL owned at the beginning of the year increased by 12.7% during the first three months of the year. After making a new purchase of 2,194 shares during the most recent quarter, Blair William & Co., IL, now owns 19,466 shares. Based on the current market price, these shares are worth $2,136,000. During the first three months of 2018, Sei Investments Co. increased the number of Novo Nordisk A/S shares that it owned by 17.5%, bringing the total number of shares it owned to a total of 1. During the most recent period of the company’s fiscal year, Sei Investments Co. made an additional purchase of 15,996 corporate stock, bringing the total number of shares held by the company to 107,175 with a value of $11,913,000 per share. To the tune of 6.09% of the company’s shares, hedge funds and other institutional investors are the owners of those shares.

During Thursday’s trading session, the price of a share of Novo Nordisk A/S fell by $0.42, bringing the total value of the company’s stock to $139.34. The company’s stock was involved in 22,914 transactions, with an average volume of 1,515,554 shares traded each time. The stock’s moving average over the past 50 days is $127.57; over the past 200 days, it has been trading at $114.30. The debt-to-equity ratio is 0.31, the current ratio is 0.92, and the quick ratio is 0.74. All of these numbers are relative to one another. These numbers can all be understood by one another. The stock has a market capitalization of $315.32 billion, a price-to-earnings-growth ratio of 1.74, a price-to-earnings ratio of 41.47, and a beta value of 0.50. The price-to-earnings growth ratio measures

Tags

Leave a comment

Your email address will not be published. Required fields are marked *